United Therapeutics Corporation
Hedge Funds Holdings
Last updated:
United Therapeutics Corporation‘s stocks are currently a part of 412 hedge funds’ portfolios, which represents 84.33% of the total amount of its stocks outstanding. This makes up a total of 40.56M shares of United Therapeutics Corporation. Compared to the previous quarter, the number fell by -5.40% or -2.31M shares fewer. As for the holding position changes, 38.35% (158) of current hedge fund investors increased the number of shares held, 35.44% (146) of current holders sold a part of the shares held, and 14.08% (58) closed the holdings completely. 46 hedge funds are new holders of United Therapeutics Corporation stock in Q3 2022, it is 11.17% of total holders.
Hedge funds holding United Therapeutics (Q4 2017 – Q3 2022)
| Q4 2017 | 394 |
|---|---|
| Q1 2018 | 366 |
| Q2 2018 | 366 |
| Q3 2018 | 361 |
| Q4 2018 | 353 |
| Q1 2019 | 371 |
| Q2 2019 | 312 |
| Q3 2019 | 294 |
| Q4 2019 | 311 |
| Q1 2020 | 294 |
| Q2 2020 | 341 |
| Q3 2020 | 323 |
| Q4 2020 | 347 |
| Q1 2021 | 381 |
| Q2 2021 | 393 |
| Q3 2021 | 412 |
| Q4 2021 | 405 |
| Q1 2022 | 413 |
| Q2 2022 | 460 |
| Q3 2022 | 412 |
Hedge funds changes in United Therapeutics positions (Q4 2017 – Q3 2022)
| Q4 2017 | 61 | 134 | 137 | 32 | 30 |
|---|---|---|---|---|---|
| Q1 2018 | 34 | 124 | 154 | 53 | 1 |
| Q2 2018 | 32 | 140 | 126 | 30 | 38 |
| Q3 2018 | 33 | 130 | 125 | 34 | 39 |
| Q4 2018 | 42 | 108 | 138 | 48 | 17 |
| Q1 2019 | 48 | 131 | 128 | 30 | 34 |
| Q2 2019 | 56 | 92 | 130 | 107 | -73 |
| Q3 2019 | 33 | 85 | 130 | 51 | -5 |
| Q4 2019 | 65 | 103 | 91 | 41 | 11 |
| Q1 2020 | 49 | 92 | 97 | 63 | -7 |
| Q2 2020 | 88 | 104 | 106 | 38 | 5 |
| Q3 2020 | 44 | 122 | 115 | 59 | -17 |
| Q4 2020 | 68 | 98 | 140 | 41 | 0 |
| Q1 2021 | 70 | 111 | 151 | 32 | 17 |
| Q2 2021 | 52 | 118 | 157 | 39 | 27 |
| Q3 2021 | 54 | 151 | 145 | 30 | 32 |
| Q4 2021 | 53 | 139 | 156 | 57 | 0 |
| Q1 2022 | 62 | 140 | 152 | 46 | 13 |
| Q2 2022 | 94 | 149 | 154 | 42 | 21 |
| Q3 2022 | 46 | 158 | 146 | 58 | 4 |
Hedge funds changes in United Therapeutics stock options (Q4 2017 – Q3 2022)
| Q4 2017 | 20,359,000 | 22,955,000 |
|---|---|---|
| Q1 2018 | 18,862,000 | 22,772,000 |
| Q2 2018 | 31,483,000 | 25,401,000 |
| Q3 2018 | 26,534,000 | 25,691,000 |
| Q4 2018 | 6,274,000 | 9,310,000 |
| Q1 2019 | 30,480,000 | 56,349,000 |
| Q2 2019 | 26,859,000 | 34,688,000 |
| Q3 2019 | 32,557,000 | 31,199,000 |
| Q4 2019 | 22,586,000 | 22,515,000 |
| Q1 2020 | 23,139,000 | 14,632,000 |
| Q2 2020 | 18,938,000 | 14,779,000 |
| Q3 2020 | 11,414,000 | 5,859,000 |
| Q4 2020 | 36,251,000 | 14,747,000 |
| Q1 2021 | 74,795,000 | 72,118,000 |
| Q2 2021 | 41,902,000 | 22,824,000 |
| Q3 2021 | 40,696,000 | 74,250,000 |
| Q4 2021 | 39,558,000 | 18,839,000 |
| Q1 2022 | 66,067,000 | 52,056,000 |
| Q2 2022 | 61,621,000 | 29,739,000 |
| Q3 2022 | 87,915,000 | 45,705,000 |